怡康医药YIKANG品牌怎么样 申请店铺

我要投票 怡康医药YIKANG在医疗器械行业中的票数:784 更新时间:2026-02-13
怡康医药YIKANG是哪个国家的品牌?「怡康医药YIKANG」是 西安怡康医药连锁有限责任公司 旗下著名品牌。该品牌发源于陕西省西安市,在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力怡康医药YIKANG品牌出海!将品牌入驻外推网,定制怡康医药YIKANG品牌推广信息,可以显著提高怡康医药YIKANG产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

怡康医药YIKANG怎么样

陕西怡康医药有限责任公司成立于2001年,目前拥有全资及控股公司14家,全省连锁葯店700余家,经营范围涵盖化学药制剂、抗生素、生化药品、生物制品、中成药、中药饮片、中药材、医疗器械、保健品、消毒用品等,经营品规10000多种。药品配送覆盖全省85%以上的地区,约107个县,企业员工6000余人,年度总销售额可达60亿元。

陕西怡康医药有限责任公司以医药经营为核心,业务覆盖了医药零售批发、医药物流、医药电商三大业务板块。批发销售网络覆盖省内各地市级医院及部队医院;市、县、乡镇,配送区域至:延安宝塔区、延长县、延川县、渭南市富平县、安康市汉滨区、西安市周至县、雁塔区等范围,并于2014年9月份成功入围宝鸡市高新区、扶风县、凤县“三统一”中标药品配送。经由2016年整合统计,陕西怡康医药现配送网络已覆盖各区县级及基层医疗机构,配送医疗机构约7000家,覆盖率100%,药品配送率达95%以上,累计销售逐年递增;公司配送中心库房总面积11000平方米,库房总面积11000平米,库存品规10000多个,拥有配送车辆近50辆,冷链车20辆。广阔的网络体系和信息化、自动化的运营体系,科学、合理、严谨的管理模式,以KSOA企业信息融通平台、WMS仓储管理、协同商务、U890用友财务、GPS定位系统、HR人力资源软件等现代化管理体系为业务、仓储、上下游客户、财务,物流、人力六大系统服务,使管理更加流程化、科学化。

2016年集团公司特斥资近2亿元倾力打造了总建筑面积5万余平米的“怡康医药集团物流中心”,集办公、物流配送及生活服务为一体,并按照新版GSP要求配备完善的温湿度、自动监控等基础设施;优良的电子分拣系统,大大提高了复核分拣效率,堪称现代医药企业办公中心典范;2014年开始布局医药电商。2015年7月7日“怡康到家”APP正式上线,标志着怡康医药从传统医药零售,迈入了以怡康到家自有平台和天猫、京东、百度等第三方平台相结合的立体化销售模式。


Shaanxi Yikang Pharmaceutical Co., Ltd. was founded in 2001. At present, it has 14 wholly-owned and holding companies and more than 700 chain drugstores in the province. Its business scope covers chemical pharmaceutical preparations, antibiotics, biochemical drugs, biological products, Chinese patent medicine, Chinese herbal medicines, medical devices, health care products, disinfection products, etc., with more than 10000 product specifications. Drug distribution covers more than 85% of the province, about 107 counties, with more than 6000 employees, and the total annual sales volume can reach 6 billion yuan. Shaanxi Yikang Pharmaceutical Co., Ltd. takes pharmaceutical business as the core, covering three business sectors: pharmaceutical retail and wholesale, pharmaceutical logistics and pharmaceutical e-commerce. The wholesale sales network covers all municipal hospitals and military hospitals in the province; cities, counties and towns, and the distribution areas are: Baota District, Yanchang County, Yanchuan County, Fuping County, Weinan City, Hanbin District, Ankang City, Zhouzhi County and Yanta District of Xi'an City, etc. in September 2014, it was successfully shortlisted for the "three unified" bid winning drug distribution in Baoji high tech Zone, Fufeng County and Fengxian County. According to the integrated statistics in 2016, the distribution network of Shaanxi Yikang Pharmaceutical Co., Ltd. now covers county-level and grass-roots medical institutions in all regions, with 7000 distribution medical institutions, 100% coverage, and more than 95% drug distribution rate, with the cumulative sales increasing year by year; the total area of the company's distribution center warehouse is 11000 square meters, with 11000 square meters, more than 10000 inventory specifications, nearly 50 distribution vehicles, and cold 20 chain cars. Wide network system, information and automation operation system, scientific, reasonable and rigorous management mode, and six systems of business, storage, upstream and downstream customers, finance, logistics and human resources, which are modern management systems such as ksoa enterprise information fusion platform, WMS storage management, collaborative business, u890 UFIDA finance, GPS positioning system, HR human resources software, etc., serve to make management more efficient Add process and scientific. In 2016, the group company invested nearly 200 million yuan to build the "Yikang Pharmaceutical Group Logistics Center" with a total building area of more than 50000 square meters, integrating office, logistics distribution and life services, and equipped with complete temperature and humidity, automatic monitoring and other infrastructure according to the requirements of the new GSP. The excellent electronic sorting system has greatly improved the efficiency of recheck sorting, which can be called the modern pharmaceutical enterprise office Model of public center; medical e-commerce began to be distributed in 2014. On July 7, 2015, "Yikang home" app was officially launched, marking that Yikang medicine has entered into a three-dimensional sales mode combining Yikang home's own platform with tmall, JD, Baidu and other third-party platforms from traditional medicine retail.

本文链接: https://brand.waitui.com/0bd2ddbd5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

人民币汇率升破6.90,盘中创近三年来新高

2月12日,在岸、离岸人民币对美元汇率双双升破6.90关口,盘中创下2023年4月以来新高。从市场归因来看,结汇盘集中释放是本轮人民币走强的核心驱动力。东方金诚首席宏观分析师王青表示,年末企业结汇需求季节性增加,叠加近期人民币持续升值,此前出口高增所累积的结汇需求有可能加速释放。(上证报)

2小时前

新基金发行火热,公募备战节后行情

2026开年以来,新基金发行火热。1月新基金发行数量达169只,达到2023年3月以来的最高水平。多只基金一日售罄,还有产品因超募触发比例配售。此外,时隔三年,市场又出现了70亿元级别的主动权益新产品。尽管春节假期临近,但在新基金发行升温的氛围下,机构已开始提前布局春节后的行情,一方面基金公司在节前启动新发,筹备节后推广;另一方面,渠道也在提前布局,抢占节后发行先机。(中证网)

2小时前

纯债基金发行降至冰点,“固收+”稳居主力地位

2026年以来,债券型基金发行整体遇冷,规模同比显著下滑,其中新发纯债基金只有寥寥数只。与之形成鲜明对比的是,“固收+”基金延续了2025年强势崛起的态势,在新发债基中占据主导地位。业内人士认为,未来居民与机构的配置需求将持续为“固收+”基金发展提供支撑,其在稳健理财领域的地位有望进一步巩固,但与此同时,行业也将面临债市收益承压、产品竞争加剧等多重挑战。(上证报)

2小时前

调仓换基增配价值品种,基金投顾开年布局求稳

2026开年以来,基金投顾调仓节奏明显加快。统计数据显示,今年1月,近650个基金投顾组合中,有178个进行调仓,增配低估值价值型基金成为共识,永赢融安、华泰柏瑞红利低波ETF联接等产品获基金投顾增配比例最高。在大类资产配置层面,基金投顾组合普遍提升了A股及债券仓位,同步减配现金资产、美股及港股持仓;行业维度则增配有色金属、电子、通信,减配生物医药、汽车及银行。(中证网)

2小时前

爱彼迎第四季度营收为28亿美元,同比增长12%

当地时间2月12日,爱彼迎公布第四季度及全年业绩报告。报告显示,第四季度爱彼迎营收为28亿美元,同比增长12%;第四季度净利润为3.41亿美元,净利润率为12%;第四季度预订总额为204亿美元,同比增长16%。2025年全年爱彼迎营收为122亿美元,同比增长10%;第四季度净利润为25亿美元,净利润率为21%;第四季度预订总额为913亿美元,同比增长12%。(界面)

2小时前

本页详细列出关于怡康医药YIKANG的品牌信息,含品牌所属公司介绍,怡康医药YIKANG所处行业的品牌地位及优势。
咨询